NIH to test Pfizer’s Paxlovid, other treatments as potential long Covid therapies
There is no proven treatment for long Covid-19, which can cause a range of debilitating symptoms in millions of Americans.
Read MoreThere is no proven treatment for long Covid-19, which can cause a range of debilitating symptoms in millions of Americans.
Read MorePfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September. Source
Read MoreSanofi said it is working with a CDC panel to include Beyfortus on the childhood immunization schedule and the Vaccines
Read MoreThibaut Mongon's remarks follow Kenvue's second-quarter earnings beat, which was fueled by resilient demand for brands like Band-Aid, Tylenol and
Read MoreJ&J owns nearly 90% of Kenvue shares and plans to reduce its stake in the company through an exchange offer
Read MoreThe results come amid investor anxiety over the thousands of lawsuits claiming that J&J's talc-based baby powder and other products
Read MorePfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands
Read MoreFDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV Source link
Read MoreWomen could face barriers to obtain Opill because health insurance is not currently required to cover birth control without a
Read More